{"title": "Open Clinical Trials | Sanford Health", "author": null, "url": "https://research.sanfordhealth.org/clinical-research/open-clinical-trials", "hostname": "sanfordhealth.org", "description": "Use this page to search all trials that are open to enrollment for adult and pediatric patients.", "sitename": "Sanford Research", "date": "2021-09-15", "cleaned_text": "View All Open Clinical Trials Use this page to search all trials that are open to enrollment for adult and pediatric patients. For more information on clinical trials at Sanford Health, call or email Bemidji Clinical Research at [(218) 333-4869](tel:1-218-333-4869), Bismarck Clinical Research at [(701) 323-5760](tel:1-701-323-5760), Fargo at 234-2383](tel:701-234-2383); and Sioux Falls Clinical Research at [(605) 328-1368](tel:1-605-328-1368). You can also learn more by visiting [clinicaltrials.gov](https://clinicaltrials.gov/), which is a comprehensive national registry of all clinical trials. Blinded Reference Set For Multicancer Early Detection Blood Tests A Phase II Study of Checkpoint Blockade Immunotherapy in Patients with Somatically Hypermutated Recurrent Glioblastoma A Phase III Trial of Stereotactic Compared with Hippocampal-Avoidant Whole Brain Radiotherapy (HA-WBRT) Plus Memantine for 5 or more Brain Metastases Phase III Trial of Salvage Stereotactic Radiosurgery (SRS) or SRS + Hippocampal-Avoidant Whole Brain Radiotherapy (HA-WBRT) for First or Second Distant Brain Relapse After Upfront SRS With Brain Metastasis Velocity 4 Brain Metastases/Year A Phase III Trial of Lomustine-Temozolomide Combination Therapy Versus Standard Temozolomide in Patients with Methylated MGMT Promoter Glioblastoma A Single Arm, Pilot Study of Ramipril for Preventing Radiation-Induced Cognitive Decline in Glioblastoma (GBM) Patients Receiving Brain Radiotherapy The COMPASSHER2 Trials (COMprehensive Use of Pathologic Response ASSessment to Optimize Therapy in HER2-Positive Breast Cancer): COMPASSHER2 Residual Disease (RD), A Double-Blinded, Phase III Randomized Trial of T-DM1 and Placebo Compared with T-DM1 and Tucatinib All-in-One nanoparticles for breast cancer treatment based on phototherapy and chemodynamic therapy Breast Cancer Bone Metastasis Testbeds Tailor RT: A Randomized Trial of Regional Radiotherapy in Biomarker Low Risk Node Positive Breast Cancer and T3N0 Breast Cancer Randomized Non-Inferiority Trial Comparing Overall Survival of Patients Monitored with Serum Tumor Marker Directed Disease Monitoring (STMDDM) versus Usual Care in Patients with Metastatic Hormone Receptor Positive HER-2 Negative Breast Cancer A Phase II Randomized Trial of Olaparib (NSC-747856) Administered Concurrently with Radiotherapy Versus Radiotherapy Alone for Inflammatory Breast Cancer Cluster Randomized Controlled Trial of Patient and Provider Decision Support to Increase Chemoprevention Informed Choice Among Women with Atypical Hyperplasia or Lobular Carcinoma In Situ - Making Informed Choices On Incorporating Chemoprevention into Care (MiCHOICE) (CompassHER2-pCR): Preoperative THP and postoperative HP in patients who achieve a pathologic complete response Part 1 Component of: The CompassHER2 Trials (COMprehensive use of Pathologic response ASSessment to optimize therapy in HER2-positive breast cancer) A Randomized, Double-blind, Placebo-controlled, Phase 3 Study of Pembrolizumab Plus Chemotherapy Versus Placebo Plus Chemotherapy for the Treatment of Chemotherapy-Candidate Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative (HR+/HER2-) Metastatic Breast Cancer (KEYNOTE-B49) Phase III Clinical Trial Evaluating De-Escalation of Breast Radiation for Conservative Treatment of Stage 1, Hormone Sensitive HER2-Negative, Oncotype Recurrence Score < 18 Breast Cancer (DEBRA) De-Escalation of Breast Radiation SH ABCD: Autoantibodies in Breast Cancer Detection Establishment of a National Biorepository to Advance Studies of Immune-Related Adverse Events A Randomized, Double-Blind, Placebo-Controlled Phase II Study of Oxybutynin versus Placebo for Treatment of Hot Flashes in Men Receiving Androgen Deprivation Therapy A Randomized Phase III Trial of Olanzapine Versus Megestrol Acetate for Cancer-Associated Anorexia Immune Checkpoint Inhibitor Toxicity (I-CHECKIT): A Prospective Observational Study Ostomy Telehealth Self-Management Training for Cancer Survivors SH Nucleotides in Colorectal Cancer Prospective cohort study embedded into integrated health care systems in the US to study cancer etiology, prevention, and early detection (Study Documentation avail-see Clinical Research) Phase 1/2 Study of 9-ING-41, a Glycogen Synthase Kinase-3 Beta (GSK-3) Inhibitor, as a Single Agent Combined with Chemotherapy, in Patients with Refractory Hematologic Malignancies or Solid Tumors A Phase III Trial of Perioperative Versus Adjuvant Chemotherapy for Resectable Pancreatic Cancer Phase II Randomized, Prospective Trial of Lutetium Trial of Olaparib + Pembrolizumab vs. Olaparib Alone as Maintenance Therapy in Metastatic Pancreatic Cancer Patients with Germline BRCA1 or BRCA2 Mutations A Randomized Phase III Study of Immune Checkpoint Inhibition with Chemotherapy in Treatment-Na\u00efve Metastatic Anal Cancer Patients A Randomized Phase II Study of De-intensified Chemoradiation for Early Stage Anal Squamous Cell Carcinoma (DECREASE) A Phase III Study of Consolidative Radiotherapy in Patients with Oligometastatic HER2 Negative Esophageal and Gastric Adenocarcinoma (EGA) Comparing the Clinical Impact of Pancreatic Cyst Surveillance Programs A Randomized Phase II Study of and Nab-Paclitaxel Compared with 5-Fluorouracil, Leucovorin, and Pancreatic Cancer (GIANT) APOLLO: A Randomized Phase II Double-Blind Study of Olaparib Versus Placebo Following Adjuvant Chemotherapy in Patients with Resected Pancreatic Cancer and a Pathogenic BRCA1, BRCA2 or Perioperative Trial CORRECT-MRD II: Second ColoRectal cancer clinical validation study to predict REcurrence using a Circulating Tumor DNA assay to detect Minimal Residual Disease Colorectal Cancer Metastatic dMMR/MSI-H Immuno-Therapy (COMMIT) Study: A Randomized Study mFOLFOX6/Bevacizumab/Atezolizumab Combination Versus Single Agent Atezolizumab in the First-Line Treatment of Patients with Deficient DNA Mismatch Repair (dMMR)/Microsatellite Instability-High (MSI-H) Metastatic Colorectal Cancer Colonoscopy for 1-2 Non-Advanced Adenomatous Polyps) Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease (CIRCULATE-US) An Exploration of Rural-Urban Disparities in Colorectal Cancer Care in North Dakota through participant surveys Myopenia and Mechanisms of Chemotherapy Toxicity in Older Adults with Colorectal Cancer: The M&M Study A Phase II Study of Gemcitabine Plus Cisplatin Chemotherapy in Patients with Muscle-Invasive Bladder Cancer with Bladder Preservation for Those Patients Whose Tumors Harbor Deleterious DNA Damage Response (DDR) Gene Alterations PD-Inhibitor (Nivolumab) and VEGF with Nivolumab: A Phase III Trial in Metastatic Untreated REnal Cell CancEr [PDIGREE] MAIN-CAV: Phase III Randomized Trial of Maintenance Cabozantinib and Avelumab vs Maintenance Avelumab After First-Line Platinum-Based Chemotherapy in Patients with Metastatic Urothelial Cancer A Phase 1 Study Evaluating the Safety, Tolerability, Pharmacokinetics, and Efficacy of AMG 509 in Subjects With Metastatic Castration-Resistant Prostate Cancer Phase III Randomized Trial of Concurrent Chemoradiotherapy with or Without Atezolizumab in Localized Muscle Invasive Bladder Cancer A Prospective Observational Cohort Study to Assess miRNA 371 For Outcome Prediction in Patients With Newly Diagnosed Germ Cell Tumors Parallel Phase III Randomized Trials of Genomic-Risk Stratified Unfavorable Intermediate Risk Prostate Cancer: De-Intensification And Intensification Clinical Trial Evaluation (GUIDANCE) A Phase II Double-Blinded, Placebo Controlled Trial of Prostate Oligometastatic Radiotherapy with or without Androgen Deprivation Therapy in Oligometastatic Prostate Cancer (NRG PROMETHEAN) The Targeted Agent and Profiling Utilization Registry (TAPUR) Study Sanford Genomic Consortium Collaborative Project-Immune Profiling in Primary Immunodeficiency COMPASS: Community Oncology use of Molecular Profiling to Personalize the Approach to Specialized cancer treatment at Sanford Phase 1b/2 Basket Study of ACR-368 as Monotherapy and in Combination with Gemcitabine in Adult Subjects with Platinum-Resistant Ovarian Carcinoma, Endometrial A Randomized, Phase 2 Study Pembrolizumab and Chemotherapy With or Without MK-4830 as Neoadjuvant Treatment for High Grade Serous Ovarian Cancer A NON-RANDOMIZED PROSPECTIVE CLINICAL TRIAL COMPARING THE NON-INFERIORITY OF SALPINGECTOMY TO SALPINGO-OOPHORECTOMY TO REDUCE THE RISK OF OVARIAN CANCER AMONG BRCA1 CARRIERS [SOROCk] A Randomized Trial of Selumetinib and Olaparib or Selumetinib Alone in Patients with Recurrent or Persistent RAS Pathway Mutant Ovarian and Endometrial Cancers: A ComboMATCH Treatment Trial A Randomized Trial of Paclitaxel/Carboplatin/Maintenance Letrozole Versus in Patients Stage Serous of the Ovary or Peritoneum NRG-GY026: A PH II/III Study of Paclitaxel/Carboplatin or Either Carcinoma or Carcinosarcoma Role of tumor microenvironment on tumor progression, drug resistance and immune escape Randomized Phase II/III Trial of Adjuvant Radiation Therapy with Cisplatin, Docetaxel-Cetuximab, or Cisplatin-Atezolizumab in Pathologic High-Risk Squamous Cell Cancer of the Head and Neck Phase II Randomized Trial of Radiotherapy with or without Cisplatin for Surgically Resected Squamous Cell Carcinoma of the Head and Neck (SCCHN) with TP53 Sequencing A Phase III Randomized Study of Maintenance Nivolumab Versus Observation in Patients with Locally Advanced, Intermediate Risk HPV Positive OPSCC Phase II Randomized Trial of Neo-Adjuvant Chemotherapy Followed by Surgery and Post-Operative Radiation Versus Surgery and Post-Operative Radiation for Organ Preservation of T3 and T4a Nasal and Paranasal Sinus Squamous Cell Carcinoma (NPNSCC) A Phase II Randomized Trial of Adjuvant Therapy with Pembrolizumab After Resection of Recurrent/Second Primary Head and Neck Squamous Cell Carcinoma with High Risk Features A Phase 2 Study of Magrolimab Combination Therapy in Patients with Head and Neck Squamous Cell Carcinoma A Phase 3, Randomized, Open-label Study to Evaluate Pembrolizumab as Neoadjuvant Therapy and in Combination with Standard of Care as Adjuvant Therapy for Stage III-IVA Resectable Locoregionally Advanced Head and Neck Squamous Cell Carcinoma (LA HNSCC) A Randomized Phase II/III Trial of De-Intensified Radiation Therapy for Patients with Early-Stage, P16-Positive, Non-Smoking Associated Oropharyngeal Cancer Randomized Phase II/III Trial of Sentinel Lymph Node Biopsy Versus Elective Neck Dissection for Early-Stage Oral Cavity Cancer Phase I Trial With Expansion Cohort of DNA-PK Inhibition and IMRT In Cisplatin-Ineligible Patients with Stage 3-4 Head Neck Squamous Cell Carcinoma (HNSCC) RANDOMIZED PHASE II/III TRIAL OF RADIATION WITH HIGH-DOSE CISPLATIN (100 MG/M2) EVERY THREE WEEKS VERSUS RADIATION WITH LOW-DOSE WEEKLY CISPLATIN (40 MG/M2) FOR PATIENTS WITH LOCOREGIONALLY ADVANCED SQUAMOUS CELL CARCINOMA OF THE HEAD AND NECK (SCCHN) SH Dr. Spanos Chemokine Evaluation of the long-term tumor control of de-escalated head and neck irradiation in p16 positive oropharynx cancer in patients with minimal/no-nicotine use history Implementation and Effectiveness Trial of HN-STAR The National Myelodysplastic Syndromes (MDS) Study A Phase 2 Study to Evaluate the Safety and Efficacy of MK-1026 in Participants with Hematologic Malignancies A Multicenter, Open-label, Phase 2 Basket Study to Evaluate the Safety and Efficacy of MK-2140 in Participants with Selected Non-Hodgkin Lymphomas and Chronic Lymphocytic Leukemia Integration of Immunotherapy Into Therapy for Resected NSCLC: ALCHEMIST Chemo-IO Phase 2 Randomized Trial of Neoadjuvant or Palliative Chemotherapy with or Without Immunotherapy for Peritoneal Mesothelioma Adjuvant Lung Cancer Enrichment Marker Identification and Sequencing Trial (ALCHEMIST) MRI Brain Surveillance Alone Versus MRI Surveillance and Prophylactic Cranial Irradiation (PCI): A Randomized Phase III Trial in Small-Cell Lung Cancer (MAVERICK) A Phase II Study of AMG 510 in Participants with Previously Treated Stage IV or Recurrent KRAS G12C Mutated Non-Squamous Non-Small Cell Lung Cancer (NSC #783608) + SBRT Versus SBRT Alone in High Risk, Early Stage NSCLC PRAGMATICA - LUNG: A Prospective 749128) Plus Pembrolizumab (MK-3475; NSC 776864) Versus Standard of Care for Participants Previously Treated with Immunotherapy for Stage IV or Recurrent Non-Small Cell Lung Cancer A Randomized Phase III Trial for Surgically Resected Early Stage Non-Small Cell Lung Cancer: Crizotinib Versus Observation for Patients with Tumors Harboring the Anaplastic Lymphoma Kinase (ALK) Fusion Protein INSIGNA : A Randomized, Phase III Study of Firstline Immunotherapy Alone or in Combination with Chemotherapy in Induction/Maintenance or Postprogression in Advanced Nonsquamous Non-Small Cell Lung Cancer (NSCLC) with SIGNature-Driven Analysis Randomized Phase III Trial of MEDI4736 (Durvalumab) as Concurrent and Consolidative Therapy or Consolidative Therapy Alone for Unresectable Stage 3 NSCLC Randomized Phase III Study of Combination (osimertinib) and Bevacizumab versus AZD9291 (osimertinib) Patients with Metastatic EGFR-Mutant Non-Small Cell Lung Cancer (NSCLC) A Phase 3, Randomized, Placebo-controlled Clinical study to evaluate the Safety and Efficacy of Stereotactic Body Radiotherapy (SBRT) with or without Pembrolizumab (MK3475) in participants with medically inoperable Stages I or IIA Non-Small Cell Lung Cancer (NSCLC) (Keynote-867) Phase 3 Study of Pembrolizumab with Concurrent Chemoradiation Therapy Followed by Pembrolizumab with or without Olaparib in Stage III NSCLC Phase III Trial of Stereotactic Radiosurgery (SRS) versus Hippocampal-Avoidant Whole Brain Radiotherapy (HA-WBRT) for 10 or fewer Brain Metastases from Small Cell Lung Cancer RAndomized Phase II/III Trial of Consolidation Radiation + Immunotherapy for ES-SCLC: RAPTOR Trial Humanitarian Use Device: Optune Lua A Master to Evaluate Biomarker-Driven Therapies and Immunotherapies in Previously-Treated Non-Small Cell Lung Cancer (Lung-MAP Screening Study) Melanoma Margins Trial (MelMarT): A Phase III, Multi-Centre, Multi-National Randomised Control Trial Investigating 1cm v 2cm Wide Excision Margins for Primary Cutaneous Melanoma Phase Study versus Nivolumab plus Ipilimumab in Patients with Unresectable Stage III or Stage IV Melanoma A Phase II Study of Biomarker Driven Early Discontinuation of Anti-PD-1 Therapy in Patients with Advanced Melanoma (PET-Stop) Adjuvant MK-7684A vs. Pembrolizumab for Resected High-Risk Quadruplet Utilization After Treatment Evaluation (EQUATE): A Randomized Phase 3 Trial for Newly Diagnosed Multiple Myeloma Not Intended For Early Autologous Transplantation A Phase 1/2 Study of BMS-986315 as Monotherapy and in Combination with Nivolumab or Cetuximab in Participants with Advanced Solid Tumors A Phase 1 Study of BMS-986406, an ILT4 Myeloid-specific Antibody, as Monotherapy and Combination Therapies in Participants with Advanced Solid Tumors Molecular Analysis for Combination Therapy Choice (ComboMATCH) A Phase 1, Open-Label, Multicenter Study to Assess the Safety and Tolerability of MK-1484 as a Monotherapy and in Combination with Pembrolizumab in Participants with Advanced or Metastatic Solid Tumors A Multicenter, Open-label, Phase III Extension Trial to Study the Long-term Safety and Efficacy in Participants with Advanced Tumors Who Are Currently on Treatment or in Follow-up in a Pembrolizumab Trial A Phase 1, Open-label, Multicenter Study to Assess Safety, Tolerability, PK, and Efficacy of MK-6598 as Monotherapy and in Combination With Pembrolizumab in Participants With Advanced Solid Tumors A Phase 2 Study of Olaparib Monotherapy in Participants with Previously Treated, Homologous Recombination Repair Mutation (HRRm) or Homologous Recombination Deficiency (HRD) Positive Advanced Cancer A Multicenter, Open-label, Phase 2 Basket Study of MK-7684A, a Co-formation of Vibostolimab (MK-7684) with Pembrolizumab (MK-3475), With or Without Other Anticancer Therapies in Participants with Selected Solid Tumors A Phase I Study of NBTXR3 Activated by Radiotherapy for Patients with Advanced Cancers Treated With An Anti-PD-1 Therapy A Phase 1-2 dose-escalation and expansion study of ST316 in subjects with selected advanced unresectable and metastatic solid tumors Phase 2 Trial of Voyager V1 (Vesicular Stomatitis Virus Expressing NIS and Human Interferon Beta, VV1), in Combination with Cemiplimab in patients with Select Solid Tumors CIBMTR Research Database Umbrella Long-Term Follow-Up Protocol Use of a Clinical Screening Tool to Address Cancer Health Disparities in the NCI Community Oncology Research Program (NCORP) COG ACCL2031 A Phase Trial Evaluating for Neurocognitive Protection in Children Undergoing Cranial Radiotherapy as Part of Treatment for Primary Central Nervous System Tumors A Phase 2 Study of Reduced Therapy for Newly Diagnosed Average-RiskWNT-Driven Medulloblastoma Patients A Phase 2 Study of Dabrafenib (NSC# of Selumetinib versus Carboplatin/Vincristine in Newly Diagnosed or Previously Untreated Neurofibromatosis Type 1 (NF1) associated Low-Grade Glioma (LGG) Low-Grade Glioma (LGG) not associated with BRAFV600E Mutations or Systemic Neurofibromatosis Type 1 (NF1) A Phase 3 Study of Selumetinib (NSC# 74827, Selumetinib in Combination BRAFV600E or IDH1 Mutations COG ACNS2021, A Phase 2 Trial of Chemotherapy followed by Response-Based Whole Ventricular & Spinal Canal Irradiation (WVSCI) for Patients with Localized Non-Germinomatous Central Nervous System Germ Cell Tumor A Phase 3 Study of Sodium Thiosulfate for Reduction of Cisplatin-Induced Ototoxicity in Children with Average-Risk Medulloblastoma and Reduced Therapy in Children with Medulloblastoma with Low-Risk Features StepByStep: A Randomized Trial of a Mobile Health and Social Media Physical Activity Intervention among Adolescent and Young Adult Childhood Cancer Survivors Tool for monitoring Chemotherapy Induced Peripheral Neuropathy (CIPN) Pediatric Hepatic Malignancy International Therapeutic Trial (PHITT) Key Adverse Events after Childhood Cancer Rapid Whole Genome Sequencing (rWGS): Rapid Genomic Sequencing for Acutely Ill Patients and the Collection, Storage, Analysis, and Distribution of Biological Samples, Genomic and Clinical Data NCI-COG PEDIATRIC MATCH (MOLECULAR ANALYSIS FOR THERAPY CHOICE) MASTER VERSION CONTROL PROTOCOL EVALUATION OF LONG-TERM SAFETY IN PAEDIATRIC SUBJECTS WITH B-PRECURSOR ACUTE LYMPHOBLASTIC LEUKEMIA(ALL) WHO HAVE BEEN TREATED WITH EITHER BLINATUMOMAB BLINCYTO OR CHEMOTHERAPY, FOLLOWED BY TRANSPLANTATION (OBSERVATIONAL STUDY) ATHN 10: Leveraging the ATHNdataset to Document the State of Rare Coagulation Disorders in the United States A Phase 2 Study of Inotuzumab Ozogamicin (NSC# 772518, IND#133494) in Children or Refractory CD22+ B-Acute Lymphoblastic Leukemia (B-ALL) International Phase 3 trial Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL) testing imatinib in combination with two different cytotoxic chemotherapy backbones. A Phase 3 Randomized Trial of Inotuzumab Ozogamicin for Newly Diagnosed High-Risk B-ALL; Risk Adapted Post-Induction Therapy for High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and Disseminated B-LLy A Phase 3 Randomized Trial for Patients with De Novo AML Comparing Standard Therapy Including Gemtuzumab Ozogamicin (GO) to CPX-351 with GO, and the Addition of the FLT3 Inhibitor Gilteritinib for Patients with FLT3 Mutations Inhibitors (TKI) to Assess Treatment-Free Remission (TFR) in Pediatric Chronic Myeloid Leukemia - Chronic Phase (CML-CP) Financial Distress during Treatment for Pediatric Acute Lymphoblastic Leukemia in the United States Prospective Cohort Study to Evaluate Immunologic Response Following COVID-19 Vaccination in Children, Adolescents and Young Adults with Cancer A Randomized Phase 3 trial of Nivolumab in Combination with Chemo-immunotherapy for the Treatment of Newly Diagnosed Primary Mediastinal B-cell Lymphonma. Pediatric Acute Leukemia (PedAL) Screening Trial - Developing New Therapies for Relapsed Leukemias A prospective, open-label, active controlled, safety and efficacy study in pediatric patients requiring anticoagulation for the treatment of a venous thromboembolic event. SH Dr. Lopez Pediatric Immune Response during Lower Respiratory Tract Infection (LRTI) OBSERVATIONAL STUDY OF PEDIATRIC RHEUMATIC DISEASES THE CARRA REGISTRY Renal Tumors Classification, Biology, and Banking Study Neuropsychological, Social, Emotional and Behavioral Outcomes in Children with Cancer Neuroblastoma Biology Studies A Phase 3 Study of 131I-Metaiodobenzylguanidine (131I-MIBG) or ALK Inhibitor Therapy Added to Intensive Therapy for Children with Newly Diagnosed High-Risk Neuroblastoma (NBL) (IND# 134379) A Phase 2 or without Eflornithine (DFMO) (IND# in Children with Relapsed, Refractory or Progressive Neuroblastoma ARDS in Children and ECMO initiation strategies impact on Neuro-Development (ASCEND) A Phase 3 Study of Active Surveillance for Low Risk and a Randomized Trial of Carboplatin vs. Cisplatin for Standard Risk Pediatric and Adult Patients with Germ Cell Tumors AGCT1532, Phase 3 Accelerated BEP Trial: A randomised phase 3 trial of accelerated versus standard BEP chemotherapy for patients with intermediate and poor-risk metastatic germ cell tumours A Phase 3 Randomized Controlled Trial Comparing Open vs Thoracoscopic Management of Pulmonary Metastases in Patients with Osteosarcoma A Randomized Phase 3 Trial of Vinorelbine, Dactinomycin, and Cyclophosphamine (VINO-AC) plus Maintenance Vincristine, Dactinomycin and Cyclophosphamine in Patients with High Risk Rhabdomyosarcoma (HR-RMS) Treatment of Newly Diagnosed Diffuse Anaplastic Wilms Tumors and Relapsed Favorable Histology Wilms Tumors Cincinnati Children's Sickle Cell Disease Caregiver Immunization Survey Siplizumab in T1DM. A T cell phenotype signature driven dose finding study with an Investigational Agent in type 1 diabetes mellitus safety follow up study with the main objective to determine long-term safety and durability response after treatment with teplizumab SH Dr. Griffin PLEDGE Monitoring Sanford Population Level Estimate of Type 1 Diabetes Risk GEnes in Children Natural History Study of The Development of Type 1 Diabetes A Phase 2a Double Blind, Placebo Controlled Study to Evaluate the Safety, Tolerability, Pharmacodynamics, and Efficacy of CNP-104 in Subjects Ages 18-75 with Primary Biliary Cholangitis Who Are Unresponsive to UDCA and/or OCA Limited access protocol for the use of oral cisapride in the treatment of pediatric patients with refractory gastroesophageal reflux disease and other gastrointestinal motility disorders. Effect of Vagus Nerve Preservation During Gastric Bypass on Gastrin Level and Marginal Ulcer Formation Impact of a PGx Clinic visit on PGx Guided Medication Outcomes SH Sanford Polygenic Risk ScOre ReTurn of REsults for Coronary Artery Disease Sanford Polygenic Risk Score in Cardiology [Working Title] Validation of multicenter, randomized, double-blind, parallel-group, placebo-controlled study to evaluate the efficacy and safety of finerenone on morbidity and mortality in participants with heart failure (NYHA II-IV) and left ventricular Papyrus Covered Coronary Stent System is a Humanitarian Use Device approved under a Humanitarian Device Exemption HF2 Registry - Hemodynamic Frontiers in Heart Failure Registry A randomized, controlled, multicenter, open-label trial comparing a hospital post-discharge care pathway involving aggressive LDL-C management that includes inclisiran with usual care versus usual care alone in patients with a recent acute coronary syndrome Clinical Trial of Atrial Fibrillation Patients Comparing Left Atrial Appendage Occlusion Therapy to Non-Vitamin K Antagonist Oral Anticoagulants AnaLysIs of Both Sex and Device Specific FactoRs on Outcomes in PAtients with Non-Ischemic Cardiomyopathy A randomized, double-blind, placebo-controlled, multicenter trial, assessing the impact of inclisiran on major adverse cardiovascular events in participants with established cardiovascular disease (VICTORION-2 PREVENT) I-SPY COVID19 Response in an Adaptive Platform Trial to Reduce Mortality and Ventilator Requirements for Critically Ill Patients Multiple Patient Program for Lamprene (clofazimine) forthe treatment of Non-Tuberculous A Safer Effective Method to Control the Serum Bilirubin Extremely Premature Infants? National Registry for -19 Infections All Birth Cohort (ABC) Study Randomized Placebo-controlled Trial to Shorten Pharmacologic Treatment of Newborns with Neonatal Opioid Withdrawal Syndrome (NOWS) FOLLOW-UP STUDY Follow-up Visit of High Risk Infants Survey of Morbidity and Mortality among high risk preterm infants Study of Attitudes and Factors Effecting Preterm Infant Care Practices A Prospective Registry Study in a Global Huntingtons Disease Cohort A CHDI Foundation Project REal-World Analyses of Stroke - Thrombus Occlusion REtrieval (RESTORE) previously SOFAST HUMANITARIAN USE DEVICE: PulseRider Aneurysm Neck Reconstruction Device Defining clinically significant fatigue in Parkinson's disease SH UND Pathophysiology of orthostatic hypotension in Parkinson's Disease Attention and Memory in Parkinson's Disease Strahm-Maternal Stress and Blood Sugar Metabolism During Pregnancy Post-approval Registry Study to Evaluate the Continued Safety and Probable Benefit of the MID-C System for 5 Years Post-Implantation in Adolescent Idiopathic Scoliosis (AIS) Minimally Invasive Deformity Correction (MID-C) System - H170001 MILES Extension Study: Two and Three Year Follow Up in subjects who previously received Mesenchymal Stem Cells or Corticosteroid Injection as part of the MILES randomized clinical trial The Effects of Combination Therapy of Opioids versus Non-Opioids on Postoperative Pain Management after Knee Arthroscopic Surgery: A Prospective Randomized Controlled Study SH Dr. Thayne Munce USD Neuroimaging for MMA Fighters Trauma and mild TBI in a pediatric population: A pilot longitudinal descriptive study assessing post-concussive symptoms, functional and quality of life outcomes. SH Direct Resuscitation of the Open Peritoneum The DROP Trial A Prospective, Multicenter, Randomized, Double-blind, Placebo-controlled Large Simple Trial Evaluating the Use of BE1116 (4-Factor Prothrombin Complex Concentrate [Kcentra\u00ae/Beriplex\u00ae]) to Improve Survival in Patients with Traumatic Injury and Confirmed or Suspected Acute Major Bleeding Predicted to Receive a Large Volume Blood Product Transfusion A Prospective Study of Emergency Department / Urgent Care Revisit Rates among Discharged Rib Fracture Patients with Involvement of Community Paramedics Product Surveillance Registry (PSR) Platform Base Protocol Double Blind, Stratified, Randomized, Controlled Trial Comparing the Safety and Efficacy of Two Treatments of AMDC-USR with placebo in Female Subjects with Stress Urinary Incontinence. Safety Assessment of MRI Imaging of All Body Parts in Patients with Implanted InterStim Therapy Prospective cohort study embedded into integrated health care systems in the US to study cancer etiology, prevention, and early detection (Study Documentation avail-see Clinical Research) Cystic Fibrosis Patient Registry Observational Study of Telehealth for Remote Endpoint Assessment (OUTREACH) A Phase 3, Open-label Study Evaluating the Long-term Safety and Efficacy of VX-121 Combination Therapy in Subjects With Cystic Fibrosis The Sanford Health BioBank A Depression "}